Discovery channel feed – Endpoints News

Discovery channel feed

AstraZeneca bets cautiously on oncolytic virus discovery program, outlining $13M deal with Transgene

7 years ago

Can differences in genomic immune system signatures detect lung cancer before it takes hold?

7 years ago

How biopharma companies use NIH and vice versa

7 years ago

Penn scientists correct genetic flaw in mice fetuses, expanding in utero CRISPR reach to lung diseases

7 years ago

ViiV's Dovato wins speedy US approval with PRV, empowering GSK to muscle into Gilead's HIV empire

7 years ago

Rat study suggests Allergan's failed antidepressant rapastinel may work as opioid addiction treatment

7 years ago

The case of the missing PD-L1: UCSF sleuths devise a new ‘tumor cell vaccine’ and a checkpoint strategy that could surprise you

7 years ago

Jeff Bezos teams with Bill Gates to fund new and better ways to diagnose Alzheimer’s

7 years ago

Belgian biotech founded by University of Torino team nabs $23.5 million in Series A round

7 years ago

The top 20 preclinical biotech deals ranked by cash upfront reveals 3 big players — and some major league stinkers

7 years ago

AACR: Bay Area biotech bets on antibodies armed with immuno-stimulant to fight checkpoint-resistant cancers

7 years ago

Hacking into macrophage attack circuits, Stanford scientists pitch a better early-warning alert system for tumors

7 years ago

Merck gives King's College London, Wellcome Trust up to $340M in deal to develop non-opioid painkillers

7 years ago

CAR-T shows promise for lupus in mouse study — will it inspire hope in a beleaguered field?

7 years ago

Backed with $180M-plus in cash, I/O trailblazer Lieping Chen spotlights NextCure's preclinical work on next-gen antibody

7 years ago

Robotic pill tech found to be safe, tolerable in early human study, paving ground for oral biologics

7 years ago

Cornell researchers to launch early trial of gene therapy aimed — ultimately — at preventing Alzheimer's

7 years ago

Off-the-shelf CAR-T from stem cells? An early look at UCLA tech — licensed by Gilead

7 years ago

Applying CRISPR to Duchenne, Duke researchers spotlight 1-year mouse data in Sarepta-sponsored study

7 years ago

The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance

7 years ago

That biotech unicorn you (pick love or hate) just spotlighted some intriguing mouse (yes) data on a triple mRNA cancer therapy

7 years ago

Celgene rolls along with another epigenetic preclinical deal featuring a Canadian biotech

7 years ago

GSK, Sanofi enlist in a big genomics project aiming to map genes of half a million Finns

7 years ago

Mass cloning for neuro research? Chinese scientists report birth of five gene-edited monkeys

7 years ago

First page Previous page 5 6 789 10 11 Next page Last page